Shyama Saha is a seasoned bioinformatics and machine learning leader with over a decade of experience translating large-scale omics and clinical datasets into actionable insights. Currently a Department Manager at Novo Nordisk and co-founder of MedAi, she blends hands-on NLP/text-mining expertise with a strong background in transcriptomics, proteomics and whole-genome analysis. Her work at EMBL-EBI and Exscientia focused on extracting drug–target relationships from scientific text and deploying ML/LLM solutions for biomedical discovery. She has led cross-disciplinary teams, navigated patient-level cancer datasets, and built bioinformatics tools that bridge research and product. Notably, she pairs a PhD in Bioinformatics with practical software engineering experience from early EMBL-EBI roles, giving her a rare mix of research rigor and production engineering. Based in Cambridge, she combines entrepreneurial drive with domain depth to accelerate translational AI in life sciences.
11 years of coding experience
12 years of employment as a software developer
Doctor of Philosophy - PhD Bioinformatics, Doctor of Philosophy - PhD Bioinformatics at Queen Mary University of London
Contributions:29 pushes, 1 branch in 1 year 11 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.